GSK2636771
GSK2636771 is an orally bioavailable substituted benzimidazole inhibitor of the beta isomer of class I phosphoinositide 3-kinase (PI3K) with potential antineoplastic activity. GSK2636771 selectively inhibits PI3K beta kinase activity in the PI3K/Akt/mTOR pathway, which may lead to tumor cell apoptosis and inhibit the growth of tumor cells expressing PI3K beta and/or PTEN-driven tumor cells.
| Supplier | Alfa Cytology |
|---|---|
| Product # | BC0155 |
| Pricing | 25.0 mg, 50.0 mg, 100.0 mg, 200.0 mg, 500.0 mg, 1.0 g, 2.0 g, inquire |